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ABSTRACT 22 
Purpose: Peroxiredoxin-2 (PRDX-2) is an antioxidant and chaperone-like protein critical 23 
for cell function. This study examined whether the levels of lymphocyte PRDX-2 are 24 
altered over one month following ultra-endurance exercise. Methods: Nine middle-aged 25 
men undertook a single-stage, multi-day 233 km (145 mile) ultra-endurance running race. 26 
Blood was collected immediately before (PRE), upon completion/retirement (POST), and 27 
following the race at DAY 1, DAY 7 and DAY 28. Lymphocyte lysates were examined 28 
for PRDX-2 by reducing SDS-PAGE and western blotting. In a sub-group of men who 29 
completed the race (n = 4) PRDX-2 oligomeric state (indicative of redox status) was 30 
investigated. Results: Ultra-endurance exercise caused significant changes in lymphocyte 31 
PRDX-2 (F (4,32) 3.409, p=0.020, η2 =0.299): seven-days after the race, PRDX-2 levels in 32 
lymphocytes had fallen to 30% of pre-race values (p=0.013) and returned to near-normal 33 
levels at DAY 28. Non-reducing gels demonstrated that dimeric PRDX-2 (intracellular 34 
reduced PRDX-2 monomers) was increased in 3 of 4 race completers immediately post-35 
race, indicative of an “antioxidant response”. Moreover, monomeric PRDX-2 was also 36 
increased immediately post-race in 2 of 4 race-completing subjects, indicative of 37 
oxidative damage, which was not detectable by DAY 7. Conclusions: Lymphocyte 38 
PRDX-2 was decreased below normal levels 7 days after ultra-endurance exercise. 39 
Excessive accumulation of reactive oxygen species induced by ultra-endurance exercise 40 
may underlie depletion of lymphocyte PRDX-2 by triggering its turnover after oxidation. 41 
Low levels of lymphocyte PRDX-2 could influence cell function and might, in part, 42 
explain reports of dysregulated immunity following ultra-endurance exercise. 43 
44 
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INTRODUCTION  45 
 Ultra-endurance exercise is associated with increased biomarkers of inflammation 46 
(e.g., the acute phase protein C reactive protein; CRP) and the production of reactive 47 
oxygen species (ROS) [1]. Although low levels of these highly reactive molecules are 48 
important for intracellular signaling, excess ROS can overwhelm antioxidant defences, 49 
causing oxidative damage in a variety of tissues, including lymphocytes [2]. The present 50 
study examined whether peroxiredoxin-2 (PRDX-2), an antioxidant molecule important 51 
for immune function, was depleted in lymphocytes over the month following an ultra-52 
endurance running race. 53 
One of the main functions of lymphocytes, the most predominant mononuclear 54 
cells in blood, is to provide immune surveillance by detecting and eliminating cells 55 
infected with viruses and bacteria, or cells that have undergone a malignant 56 
transformation. Following ultra-endurance exercise, lymphocytes exhibit increased 57 
oxidative damage as measured by protein oxidation and DNA damage [3,4]. Conceivably, 58 
exercise-induced oxidative damage in lymphocytes might alter aspects of immunity that 59 
rely on redox homeostasis. For example, lymphocyte activation, proliferation and 60 
cytotoxicity are impaired following depletion of the peroxide-quenching antioxidant 61 
molecule glutathione [5]. Moreover, low intracellular antioxidant levels and redox-62 
sensitivity have been implicated in the reactivation of latent viruses [6] and there is 63 
substantial evidence that large volumes of exercise are associated with periods of illness 64 
[7]. Conversely, very low levels of PRDX-2 are associated with uncontrolled immune 65 
activation that might exacerbate inflammatory activity following exercise [8-10].  66 
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PRDX-2 is one of six isoforms of the peroxiredoxin family, which represent a 67 
group of multifunctional antioxidant enzymes, approximately 20-30 kDa in size [11]. All 68 
peroxiredoxin isoforms share the same antioxidant mechanism; the use of a catalytic 69 
cysteine residue to reduce peroxynitrite, hydrogen peroxide and hydroperoxides [12]. A 70 
major role for reduced peroxiredoxins is the control of redox-dependent intracellular 71 
signaling, and therefore a variety of cell functions by regulating hydrogen peroxide levels 72 
[13]. Indeed, PRDX-2 is the most abundant antioxidant enzyme in the cytosol of 73 
lymphocytes, and its levels appear to be involved in the regulation of lymphocyte 74 
function [8,14]. Conversely, monocytes, a relatively minor proportion of mononuclear cells 75 
in blood, contain little or no PRDX-2 [15]. 76 
PRDX-2 can exist in various redox states within a cell. Prior to reduction of 77 
peroxides, PRDX-2 is present as a reduced monomeric form, and upon reaction with 78 
molecules such as hydrogen peroxide, the catalytic cysteine residue becomes oxidized to 79 
form sulphenic acid in the first instance. This oxidized PRDX-2 monomer is only present 80 
transiently due to the rapid formation of a disulphide bond between the cysteine residue 81 
of a neighbouring PRDX-2 subunit, resulting in a dimer. In some circumstances PRDX-2 82 
becomes over-oxidized to form sulphinic acid, inducing a structural transition that serves 83 
to induce cell cycle arrest [16]. Oxidation of the catalytic cysteine residue to sulphinic and 84 
sulphonic acids, promotes disruption of alpha helices and the exposure of hydrophobic 85 
domains that drive the formation of stable decameric complexes of PRDX-2 [16]. In turn, 86 
decamers lack peroxidase activity, allow redox signaling and function as molecular 87 
chaperones to support the refolding of mildly-oxidized proteins [12].  88 
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We have shown previously that the levels of glutathione in whole blood are 89 
depleted for up to one month after ultra-endurance exercise [4]. Considering the majority 90 
of glutathione in whole blood is derived from erythrocytes, it remains largely unexplored 91 
whether ultra-endurance exercise depletes antioxidant defences in lymphocytes. In 92 
addition, since antioxidant molecules in lymphocytes are important for cell function and 93 
therefore immune surveillance, then depletion of these molecules might significantly 94 
affect immune function. The present study examined whether PRDX-2 level and 95 
oligomerisation is altered in lymphocytes over one month following ultra-endurance 96 
exercise. 97 
98 
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METHODS 99 
 100 
Ethical approval 101 
Informed consent was obtained in writing following ethical approval from the School of 102 
Sport and Exercise Sciences research ethics committee of the University of Birmingham 103 
(approved study number: 08/60). All procedures conformed to the standards set by the 104 
Declaration of Helsinki. 105 
 106 
Experimental design 107 
Nine healthy men (mean ± standard deviation; age 46.1 ± 5.3 years, body mass 108 
index 24.9 ± 2.3 kg.m-2, maximal oxygen consumption 56.3 ± 3.3 ml.kg-1.min-1) took part 109 
in this study as previously described [4]. Participants undertook a single-stage, multi-day 110 
233 km (145 mile) running event. The race started at 06:00 on Saturday the 23rd of May 111 
2009, and participants who completed the race, crossed the finish line between 21:15 on 112 
Sunday the 24th of May, and 01:50 on Monday the 25th of May. Diet was not controlled 113 
for logistical reasons. Participants did not rest during the race, other than for very short 114 
periods (e.g., to urinate or change clothing) and none of the participants slept.  The 115 
typical running strategy adopted by participants consisted of approximately 50-55 116 
minutes of running, with 5-10 minutes of walking (allowing for recovery and nutritional 117 
intake), repeated in cycles until the race was completed. Due to exhaustion, the final hour 118 
of exercise was typically walking. Blood samples were collected immediately before the 119 
race (PRE) and as close to the time of exercise cessation for each participant as was 120 
logistically possible, irrespective of whether they retired early or completed the race 121 
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(POST; 65 ± 64 minutes after). Additional blood samples were collected following the 122 
race at as close to 24 hours after exercise cessation as was logistically possible for each 123 
participant (DAY 1; mean 26 ± 4 hours) and seven and twenty-eight days later (DAY 7 124 
and DAY 28 respectively). Participants refrained from exercising for at least 7 days after 125 
the race. 126 
 127 
Sample preparation 128 
Plasma and peripheral blood mononuclear cells (PBMCs) were processed within 129 
60 minutes of collection and frozen at −80°C as previously described [4]. PBMCs are 130 
hereafter referred to as lymphocytes as the results reported below reflect changes in 131 
lymphocyte, and not monocyte, PRDX-2 levels: monocytes represent a small proportion 132 
of PBMCs and contain little or no detectable PRDX-2 [15]. Cell preparations were thawed 133 
and lysed using RIPA buffer (Thermo Scientific, UK) containing a protease inhibitor 134 
cocktail (Sigma Aldrich, Dorset UK). Total protein concentration was determined using 135 
the bicinchoninic acid method.  136 
 137 
Analytical procedures 138 
 Plasma CRP was measured using an immunoturbidimetric assay based upon latex 139 
particle agglutination (Tina-quant® CRP latex high sensitivity assay, Indianapolis, USA) 140 
and measured on an automated clinical chemistry analyser (Roche Hitachi Cobas). 141 
Total PRDX-2 levels and monomeric, dimeric and decameric complexes of 142 
PRDX-2 were measured by reducing and non-reducing SDS-PAGE respectively, 143 
followed by western blotting. Proteins (10 µg) were loaded 1:1 in sample buffer (4% 144 
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SDS, 20% glycerol, 0.004% bromophenol blue and 0.125 M Tris HCl, pH 6.8), with and 145 
without 10% 2-mercaptoethanol, onto 15 or 18 % polyacrylamide gels. Electrophoresis at 146 
115V was performed for approximately 1.5 hours using a Mini-PROTEAN® tetra-cell 147 
(Bio-Rad, Hemel Hempstead, UK) with electrophoresis buffer (25 mM Tris, pH 8.3, 192 148 
mM glycine, and 0.2% w/v SDS). Separated proteins were transferred to Hybond-P® 149 
PVDF membrane (GE Healthcare, Amersham, UK) with transfer buffer (25 mM Tris, pH 150 
8.3, 192 mM glycine, and 40% w/v methanol) for 2 hours at 170mA. Membranes were 151 
blocked overnight at 4ºC with 3% BSA (Sigma Aldrich, Dorset, UK) in TBS, washed 152 
three times for 10 minutes in TTBS (0.05% Tween-20) and incubated with rabbit 153 
polyclonal anti-PRDX-2 antibody (1: 1000, Ab15572, AbCam, Cambridge, UK) or 154 
mouse monoclonal anti-actin antibody (1: 10 000, Sigma Aldrich, Dorset, UK) for 2 155 
hours at room temperature. PVDF membranes were washed three times for 10 minutes in 156 
TTBS (0.05% Tween-20). PRDX-2 blots were incubated with a peroxidase conjugated 157 
goat anti-rabbit antibody (1: 5000; A6154, Sigma Aldrich, Dorset, UK), and actin blots 158 
were incubated with a peroxidase-conjugated goat anti-mouse antibody (1: 25 000, Sigma 159 
Aldrich, Dorset, UK) for 2 hours at room temperature. Membranes were washed three 160 
times for 10 minutes in TTBS (0.05%) and visualized using ECL+ chemiluminescent 161 
detection system (GE Healthcare, Amersham, UK). Protein bands were scanned using a 162 
molecular imager GS-800 calibrated densitometer (Bio-Rad) and quantified using 163 
Quantity One™ software (Bio-Rad, Hemel Hempstead, UK). Densitometry values for 164 
each protein band were recorded and expressed as arbitrary units.  165 
 166 
Data analysis 167 
 9 
Data were confirmed as having normal distribution using the Kolmogorov-168 
Smirnov test. Changes in PRDX-2 level were assessed using Analysis of Variance 169 
(ANOVA). Potential confounding factors (e.g., finishing status) were entered into 170 
ANOVAs as individual covariates and examined for significance (Analysis of co-171 
variance; ANCOVA). Effect sizes are reported as eta-squared (η2). Conventionally, η2 172 
values of 0.01, 0.06, and 0.14 are considered small, medium and large effect sizes 173 
respectively. Post-hoc paired-samples t-tests identified differences relative to baseline. 174 
Significance was set at p < 0.05. Data are presented as means ± standard error of the 175 
mean (SEM) unless otherwise stated. Data were analysed using SPSS statistical package 176 
version 18.0 for Windows (SPSS Inc., USA). 177 
178 
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RESULTS 179 
Ultra-endurance race  180 
Four men completed the race (finishers). Table 1 shows that there were no 181 
physiological differences between the finishers (n = 4) and those who retired prematurely 182 
due to exhaustion (non-finishers; n = 5). As finishing status did not influence the results 183 
reported below as shown by analysis of covariance, all men were included in the main 184 
analyses (i.e., CRP, lymphocyte and monocyte responses, total PRDX-2 level).  185 
 186 
Ultra-endurance exercise induces an inflammatory response 187 
Compared to pre-race, plasma CRP was increased approximately 100-fold 188 
immediately post-race and remained at this level for 24 hours. Seven days after the race, 189 
plasma CRP remained approximately 8-fold higher than pre-race levels, returning to 190 
normal values within one month of the race (see Figure 1, main effects of time; F (4,32) 191 
3.409, p < 0.001, η2 = 0.921). 192 
 193 
Lymphocyte and monocyte numbers before and after ultra-endurance exercise 194 
 Table 2 shows lymphocyte and monocyte counts, and the ratio between these 195 
cells, in samples collected before and after ultra-endurance exercise. Immediately after 196 
the race, there was a trend for a fall in the number of lymphocytes (i.e., lymphocytopenia) 197 
and a significant increase in the number of monocytes (i.e., monocytosis). Subsequently, 198 
there was a trend for a fall in the lymphocyte/monocyte ratio immediately after exercise. 199 
In all other post-race samples (i.e., DAY 1, DAY 7 and DAY 28 post-race) lymphocyte 200 
and monocyte counts were comparable to pre-race levels. There were no significant 201 
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differences in lymphocyte and monocyte counts in samples collected from finishers 202 
compared to non-finishers (time × finishing status interactions all; F (4,28) <1.49, p>0.05). 203 
Moreover, controlling statistically for minor fluctuations in the lymphocyte/monocyte 204 
ratio between samples did not influence the results reported below, as shown by analysis 205 
of covariance (data not shown). 206 
 207 
Lymphocyte PRDX-2 is depleted below normal levels seven days after ultra-208 
endurance exercise 209 
Ultra-endurance exercise caused a significant alteration in the level of PRDX-2 in 210 
lymphocytes (see Figure 2, main effects of time; F (4,32) 3.409, p = 0.020, η2 = 0.299). 211 
Compared to baseline there was a 17% increase in PRDX-2 level immediately after the 212 
race (paired samples t-test; t (8) – 1.605, p = 0.147). Twenty-four hours after exercise the 213 
level of PRDX-2 had fallen to 74% of pre-race values (t (8) = 0.854, p = 0.418). Seven-214 
days after exercise PRDX-2 level fell to 30% of pre-race values (paired samples t-test; t 215 
(8) 3.187, p = 0.013). Twenty eight days post-race PRDX-2 returned to a similar level to 216 
that measured twenty-four hours after the race, which was not significantly different from 217 
baseline (76% of pre-race values; paired samples t-test; t (8) 1.037, p = 0.330). 218 
 219 
Lymphocyte PRDX-2 is over-oxidized after ultra-endurance exercise  220 
 To investigate whether the changes in PRDX-2 level following ultra-endurance 221 
exercise could be explained by PRDX-2 over-oxidation, samples from a sub-group of 222 
men (n  = 4) were analysed. All men in this sub-group finished the race and their changes 223 
in PRDX-2 represented the group as a whole (n = 9). Samples were examined from the 224 
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time points that showed the most pronounced changes in PRDX-2 (i.e., PRE, POST and 225 
DAY 7). Statistical analyses were not conducted on these data. 226 
As illustrated in Figure 3, under normal intracellular conditions, PRDX-2 can 227 
exist as a monomer, dimer or decamer, dependent on redox-state. Within cells, the 228 
monomeric form typically represents reduced PRDX-2. Oxidized PRDX-2 usually forms 229 
dimers. However, when ROS are in excess, the already oxidized PRDX-2 becomes over-230 
oxidized and may exist as a monomer or as a decamer [12]. Upon cell lysis, reduced 231 
monomeric PRDX-2 undergoes mild oxidation and therefore appears as dimers on non-232 
reducing SDS-PAGE. Over-oxidized PRDX-2 usually resolves as a decamer. With 233 
excessive ROS production, PRDX-2 monomers are unable to dimerise due to over-234 
oxidation, and therefore remain as monomers on non-reducing SDS-PAGE [14].  235 
Figure 4A shows that two bands at approximately 250kDa and 50 kDa (indicative 236 
of decameric and dimeric PRDX-2 respectively) are present at baseline. For subject 1, 2 237 
and 9, the intensity of the 50kDa band (indicative of reduced/mildly oxidized PRDX-2) 238 
increased immediately post-race. Moreover, a band at approximately 25kDa (indicative 239 
of monomeric over-oxidized PRDX-2) appeared immediately post-race in subjects 2 and 240 
9. At seven days post-race, the band at 25kDa was absent in all subjects, and there was a 241 
noticeable reduction in the intensity of the 50kDa band in subjects 1, 2, and 9.  There was 242 
no noticeable change in intensity of the 50kDa and 25kDa bands post-race and seven 243 
days post-race compared to baseline in subject 8.  244 
Densitometry values of each band visible on non-reducing SDS-PAGE were 245 
expressed as a ratio of monomeric and decameric PRDX-2 (indicative of over-oxidized) 246 
to dimeric PRDX-2 (indicative of reduced/mildly-oxidized) (Figure 4B). This ratio 247 
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increased immediately after and seven days post-race, indicative of oxidative stress. 248 
Further, when monomeric and decameric PRDX-2 and dimeric PRDX-2 were expressed 249 
as a proportion of all PRDX-2 oligomers, there was a clear increase in monomeric and 250 
decameric PRDX-2 (indicative of over-oxidized) and a concomitant decrease in dimeric 251 
PRDX-2 (indicative of reduced/mildly oxidized) immediately after and seven days post-252 
race. These data suggest that ultra-endurance exercise causes over-oxidation of PRDX-2 253 
(Figure 4A). 254 
 255 
 256 
257 
 14 
DISCUSSION 258 
This study demonstrates that lymphocyte PRDX-2 is depleted to less than one-259 
third of normal levels (70% reduction) seven days after an ultra-endurance running event 260 
in nine middle-aged men. Further analyses in a sub-group of men who completed the race 261 
(n=4) indicated that in some individuals, PRDX-2 becomes over-oxidised after ultra-262 
endurance exercise and is found predominantly in the decameric or monomeric forms. 263 
Whereas over-oxidized monomeric PRDX-2 appears to be cleared within seven days, the 264 
over-oxidised decameric form seems to persist for at least seven days after ultra-265 
endurance exercise. This is the first study to examine PRDX-2 levels and redox-state in 266 
lymphocytes following exercise.  267 
There was a large decrease in lymphocyte PRDX-2 levels seven days after the 268 
race. One possible explanation for this finding is that in response to excessive ROS 269 
production, perhaps mediated by post-exercise respiratory burst [10], PRDX-2 becomes 270 
over-oxidized to the sulphinic or sulphonic forms which appear as monomers under non-271 
reducing conditions. Although low concentrations of hydrogen peroxide transiently 272 
elevate PRDX-2 [17], high concentrations lower PRDX-2 mRNA and protein expression 273 
in lymphocytes and cause PRDX-2 over-oxidation [18,19]. Over-oxidized PRDX-2 can also 274 
form decamers and exhibit chaperone-like activity to protect cellular proteins from 275 
denaturation and promote refolding [20]. Eventually, over-oxidized PRDX-2 is degraded 276 
via the proteasome, the main intracellular pathway responsible for removal of oxidized 277 
proteins [21,22] and PRDX-2 levels return to normal or even below normal levels. Our 278 
results are consistent with the turnover of over-oxidized PRDX-2 in cells. In an analysis 279 
of non-reducing SDS-PAGE in a sub-group of men who completed the race (n=4) and 280 
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were therefore exposed to an equivalent level of exercise stress, we examined the redox 281 
status of PRDX-2 at the time points exhibiting the largest changes in total PRDX-2 (i.e., 282 
PRE, POST, DAY 7) using non-reducing SDS-PAGE. Our results suggest that over-283 
oxidized monomeric PRDX-2, which increased immediately post-race, was absent seven 284 
days later, possibly indicating clearance.  285 
A second explanation and possible function of the lower lymphocyte PRDX-2 286 
levels observed seven days after exercise might be related to homeostatic replacement of 287 
damaged and/or “senescent” T lymphocytes following exercise. For example, there are 288 
reports showing that a small number of lymphocytes (1-10%) can be damaged by 289 
exercise and become apoptotic [23]. It is unlikely that this small number of apoptotic cells 290 
could account for the changes in levels of PRDX-2 in total lymphocytes directly, but 291 
PRDX-2 may be down-regulated in undamaged lymphocytes [8,9]. Such PRDX-2 down-292 
regulation, which is implicated in lymphocyte proliferation, might function to replace 293 
“senescent” cells, such as terminally differentiated virus-specific T lymphocytes, which 294 
are characteristic of an ageing adaptive immune system [24]. Indeed, it has been proposed 295 
that exercise removes excess numbers of virus-specific lymphocytes, that are normally 296 
apoptosis-resistant, to limit their accumulation during ageing and persistent infection [24]. 297 
The present results are consistent with this idea, where the down-regulation of PRDX-2 298 
may be an adaptive mechanism underlying the restorative proliferation of “healthy” cells 299 
following exercise. 300 
 There is debate as to whether the health benefits of regular physical activity 301 
extend to extreme forms of exercise. Many studies have examined oxidative damage 302 
following ultra-endurance exercise [1], and while the majority of studies report increased 303 
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biomarkers of oxidative damage in lymphocytes following exercise [3,4], others report 304 
little damage or no long lasting damage [25]. It has also been argued that the increased 305 
ROS production is beneficial, as it results in a characteristic “antioxidant response”, 306 
whereby the level of protective antioxidant enzymes is transiently elevated [26]. In the 307 
present study, there was a trend for increased lymphocyte PRDX-2 levels immediately 308 
after exercise. One explanation for this observation might be an acute antioxidant 309 
response to exercise-induced hydrogen peroxide accumulation [17], which for example, 310 
might be caused by superoxide release from mitochondria [27]. In support of this 311 
hypothesis, it has been shown experimentally that de novo synthesis of PRDX-2 occurs 312 
during, or in the hours following, an oxidative stress stimulus [18]. In addition, the 313 
increase in hydrogen peroxide level might exceed the capacity for removal due to over-314 
oxidation of PRDX-2, as shown for subjects 2 and 9 during the course of exercise (Figure 315 
3A). An alternative explanation for the elevated PRDX-2 levels observed in this study 316 
might be due to non-specific, exercise induced T lymphocyte activation, since stimulating 317 
the T cell receptor results in hydrogen peroxide-mediated signaling and a subsequent 318 
increase in PRDX-2 levels [8]. Indeed, the increased expression of lymphocyte cell 319 
surface proteins associated with activation during exercise, including CD25 (the IL-2 320 
receptor), CD69 and HLA-DR, suggests that exercise can directly activate T lymphocytes 321 
in peripheral blood [28].  322 
The lower PRDX-2 levels in lymphocytes following ultra-endurance exercise in 323 
the present study, might be an attractive mechanism to examine in future studies 324 
attempting to understand the reports of dysregulated immunity (i.e., inflammatory activity 325 
and upper respiratory tract infections; URTI) following extreme exercise [7,29]. While 326 
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glutathione depletion is associated with viral reactivation and impaired lymphocyte 327 
function [6], lower than normal levels of PRDX-2 are associated with the reverse: 328 
uncontrolled and inappropriate immune activation [8]. PRDX-2 is a critical regulator of 329 
cell-mediated immunity and animals lacking the PRDX-2 gene show uncontrolled 330 
expansion of CD8+ T lymphocytes in models of chronic infection, which results in lethal 331 
immunopathology [8]. Therefore, low levels of PRDX-2 in CD8+ T lymphocytes might 332 
exaggerate inflammatory responses in the days following exercise, considering these cells 333 
are potent producers of IFN-γ, TNF-α and IL-6 [30,31]. In the present study, CRP, an acute 334 
phase reactant released from the liver in response to IL-6, was approximately 100-fold 335 
higher than normal for at least 24 hours after ultra-endurance exercise. Values close to 336 
100 mg/L, as reported in the present study, are typically associated with major bacterial 337 
infections. Seven days after ultra-endurance exercise, CRP was approximately 8-fold 338 
higher than normal levels, which returned to pre-race values within one month of the 339 
race. Considering CRP has a half life of 4-6 hours, the present results show that ultra-340 
endurance exercise results a temporary period (i.e., 7 days) of inflammation that is akin to 341 
inflammatory disorders. Interestingly, individuals with larger-than-normal inflammatory 342 
responses to environmental stressors are more likely to exhibit symptoms of URTI, than 343 
individuals with normal inflammatory responses [32]. 344 
It should be considered that in the present study PRDX-2 was measured in 345 
PBMCs, a heterogenous population of cells consisting mostly of lymphocytes but also 346 
some monocytes. While the majority of PRDX-2 would have been derived from 347 
lymphocytes as monocytes contain little or no PRDX-2 [15], the results could in principle, 348 
be influenced by the proportion of each cell type in the samples. For example, in the 349 
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present study, samples collected immediately post-race contained fewer lymphocytes and 350 
more monocytes compared to pre-race samples. Despite normalising for total protein 351 
assayed, compared to pre-race, a larger proportion of the protein was derived from 352 
monocytes post-race. Thus, it might be expected for the level of PRDX-2 to fall. In the 353 
present study however, the opposite was true: there was a trend for an increase in PRDX-354 
2 immediately post-race, presumably evidence of an “antioxidant response”. Moreover, 355 
the main finding that lymphocyte PRDX-2 is depleted below normal levels seven days 356 
after ultra-endurance exercise, is derived from comparing two blood samples collected at 357 
rest (i.e., PRE vs. DAY 7), in which the proportion of lymphocytes and monocytes were 358 
comparable. 359 
The present study describes for the first time the kinetics of PRDX-2 360 
oligomerisation and expression level in lymphocytes following ultra-endurance exercise. 361 
Although PRDX-2 has not been examined previously following this type of exercise, 362 
increased concentrations of the antioxidant molecule thioredoxin-1 has been reported in 363 
plasma immediately after ultra-endurance exercise [33]. In the context of the present 364 
results, an increase in thioredoxin-1 might be part of the antioxidant response to exercise, 365 
which serves to recycle mildly oxidized PRDX-2 following exercise-induced hydrogen 366 
peroxide production. In the context of chronic exercise training, PRDX-2 levels have 367 
been shown to elevated in erythrocytes [34] but not in muscle [35] after three months of 368 
moderate intensity cycling.  369 
Taken together with existing literature, the present results indicate that exercise 370 
causes time-dependent changes in the level, redox-state and likely turnover of PRDX-2, 371 
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which may be a consequence of excess ROS production in lymphocytes. The 372 
immunological consequences of these observations remain to be elucidated.   373 
 374 
 375 
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 377 
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TABLES 527 
Table 1.  Characteristics of finishers and non-finishers (mean ± standard deviation).  528 
 Finishers (n=4) a, Non-finishers (n =5) b  
Age (years) 43 ± 3 49 ± 6 p >.05 
Body Mass Index (Kg.m2) 23.7 ± 1.3 25.8 ± 2.7 p >.05 
Body Fat (%) 14.0 ± 1.3 14.2 ± 3.3 p >.05 
LTPAc (MET.min.week-1) 2837 ± 911 4116 ± 931 p >.05 
VO2max (ml.kg-1.min-1) 58.6 ± 3.1 54.5 ± 2.2 p >.05 
Max Heart Rate (bpm) 174 ± 4 176 ± 5 p >.05 
Running distance (km) 233.4 ± 0.0 126.7 ± 29.7 p <.01 
Running duration (hh:mm) 41:40 ± 2:13 20:44 ± 7:15 p <.01 
Running speed (km/h) 5.6 ± 0.7 6.6 ± 0.7 p >.05 
 529 
a independent samples t-test between finishers and non-finishers 530 
b Finishing status did not confound the changes in lymphocyte peroxiredoxin-2 level as 531 
determined by analysis of covariance. 532 
c Leisure Time Physical Activity, as assessed by the international physical activity 533 
questionnaire (IPAQ) 534 
 535 
 536 
 537 
 538 
 539 
 540 
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Table 2. Lymphocyte and monocyte numbers 541 
 542 
Cells x109 PRE POST DAY 1 DAY 7 DAY 28 Main effects of time Time × Finishing 
status interaction 
Lymphocytes 2.56 ± 0.82 2.03 ± 0.73 2.27 ± 0.50 2.08 ± 0.44 2.24 ± 0.54 F (4,28) 2.45, p=0.069 F (4,28) 1.48, p>0.05 
Monocytes 0.34 ± 0.16 0.68 ± 0.36* 0.41 ± 0.27 0.30 ± 0.09 0.36 ± 0.21 F (4,28) 4.08, p=0.010 F (4,28) 0.95, p>0.05 
Lymph/Mono 9.22 ± 6.00 3.92 ± 2.74 7.84 ± 4.92 7.49 ± 2.84 9.53 ± 7.29 F (4,28) 1.87, p>0.05 F (4,28) 0.78, p>0.05 
 543 
* p < 0.05 paired samples t-test compared to PRE 544 
 545 
 546 
 547 
 548 
 549 
 550 
 551 
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FIGURE CAPTIONS 552 
Figure 1. Plasma CRP increases in response to ultra-endurance running (n=9). *** 553 
p<0.001 compared to PRE. 554 
 555 
Figure 2. Total PRDX-2 levels in response to ultra-endurance running. A) Bars 556 
represent total PRDX-2 levels in lymphocyte cell lysates (n=9). Error bars indicate mean 557 
± SEM. PRDX-2 was depleted below pre-race levels seven days after ultra-endurance 558 
exercise. B) Representative western blots of lymphocyte cell lysates under reducing 559 
conditions.  560 
 561 
Figure 3. PRDX-2 oligomeric states. A) Cellular PRDX-2 oligomers: reduced PRDX-2 562 
monomers can be oxidized to sulphenic acid. This mildly oxidized monomer can be 563 
attacked by a neighbouring cysteine on a PRDX-2 subunit to form an inter-disulphide 564 
bond resulting in an oxidized dimer, or over-oxidized to sulphinic or sulphonic acid, 565 
which in turn can form over-oxidized decamers. B) PRDX-2 oligomers under non-566 
reducing conditions: upon cell lysis, reduced monomeric PRDX-2 undergoes mild 567 
oxidation to sulphenic acid and resolves as dimers (50kDa), whereas over-oxidized 568 
PRDX-2 can either exist as a decamer (250kDa) and also as a monomer (25kDa). 569 
 570 
Figure 4. PRDX-2 redox state in response to ultra-endurance running (n = 4; 571 
finishers only).  A) Western blots for decameric, dimeric and monomeric forms of 572 
PRDX-2 in lymphocyte cell lysates under non-reducing conditons (n=4; all men finished 573 
the race). PRE, POST and DAY 7 time points were selected to examine the most 574 
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pronounced changes in PRDX-2 level. Over-oxidation of PRDX-2 can be seen 575 
immediately post-race as shown by a 25kDa band that is prominent in subjects 2 and 9, 576 
which is absent seven days later. B) PRDX-2 level represented as a ratio of over-oxidized 577 
to reduced/mildly oxidized PRDX-2. C) Over-oxidized and reduced/mildly oxidized 578 
PRDX-2 expressed as a percentage of all PRDX-2 oligomers present under non-reducing 579 
conditions. 580 
 581 
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